TAF II p105 activators are a class of molecules that target and enhance the function of the TAF II p105 protein, formally known as TAF1. TAF1 is a subunit of the transcription factor IID (TFIID) complex, which plays a critical role in the initiation of gene transcription by RNA polymerase II. TAF1, in particular, is the largest component of the TFIID complex and possesses several distinct domains responsible for various interactions and enzymatic activities, including kinase, ubiquitin-activating/conjugating, and histone acetyltransferase activities. These enzymatic functions contribute to the regulation of transcription initiation by modulating the chromatin structure and recruiting other components of the transcription machinery. TAF II p105 activators are designed to enhance the functional properties of TAF1, thereby promoting the transcriptional readiness of genes and influencing the rate and pattern of gene expression.
The mechanism by which TAF II p105 activators work could involve increasing the enzymatic activity of TAF1 or promoting its interaction with other TFIID subunits and transcriptional regulators. By stabilizing the formation of the TFIID complex or enhancing TAF1's binding to promoter regions of genes, these activators could positively influence the transcription initiation process. The design of TAF II p105 activators requires a detailed understanding of the structural features of TAF1, including the domains that mediate its interactions and the post-translational modifications that regulate its activity. Moreover, the development of these compounds necessitates knowledge of the dynamic process of transcription initiation and the precise role TAF1 plays within that process.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, as a potent histone deacetylase inhibitor, can enhance transcription by unwinding chromatin, facilitating access for transcription factors, and potentially leading to the upregulation of TAF II p105 expression through increased promoter accessibility. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound can hinder DNA methylation, which normally suppresses gene expression. By blocking this suppression, 5-Azacytidine could lead to the elevated transcription of TAF II p105 by enabling transcription factors to bind more freely to the DNA. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating intracellular cAMP levels, forskolin can activate cAMP response element-binding protein (CREB), which may bind to the TAF II p105 promoter region to stimulate its transcription. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate protein kinase C, which may trigger a cascade of downstream signaling events leading to the activation of transcription factors responsible for the increased transcription of TAF II p105. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can engage nuclear receptors that bind to responsive elements in DNA, potentially promoting the transcription of target genes, including TAF II p105, by recruiting coactivators to the transcription complex. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
This estrogen can bind estrogen receptors, which then translocate to the nucleus and directly bind to estrogen response elements in the DNA, possibly initiating the transcription of TAF II p105 by enhancing the assembly of the transcription machinery at its promoter. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can activate glucocorticoid receptors, which translocate to the nucleus and may stimulate the transcription of TAF II p105 by interacting with glucocorticoid response elements in its promoter region, promoting the recruitment of transcriptional machinery. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can inhibit GSK-3, an enzyme that regulates a plethora of transcription factors. The inhibition of GSK-3 by lithium could potentially lead to the stimulation of TAF II p105 transcription through enhanced transcription factor activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Similar to TSA, sodium butyrate's inhibition of histone deacetylase can lead to a more relaxed chromatin state, thereby potentially facilitating the transcriptional machinery's access to the TAF II p105 promoter and elevating its transcription levels. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
While primarily used as a solvent, DMSO can induce differentiation in certain cell types, which is often accompanied by a shift in gene expression patterns. This differentiation effect could lead to the elevated expression of genes including TAF II p105. | ||||||